ARTICLE | Clinical News
ALS-357 regulatory update
September 3, 2007 7:00 AM UTC
FDA granted Orphan Drug designation for ALS-357 to treat metastatic melanoma. ADLS plan to start a Phase I/II trial of the topical pentacyclic triterpenoid early next year. ...